Neonatal Abstinence Syndrome

• Autores: Kathryn Dee Lizcano MacMillan
• Localización: Clinics in Perinatology, ISSN 0095-5108, Vol. 46, Nº. 4, 2019 (Ejemplar dedicado a: Anesthesia, Sedation, and Pain Control), págs. 817-832
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • The incidence of neonatal abstinence syndrome owing to prenatal opioid exposure has grown rapidly in recent decades and it disproportionately affects rural, non-white, and public insurance–dependent populations. Treatment consists of pharmacologic and nonpharmacologic interventions with wide variability in approaches across the United States. Standardizing clinical assessment, minimizing unnecessary interruptions, and prioritizing nonpharmacologic and family-centered care seems to improve hospital outcomes. Neonatal abstinence syndrome may have long-term developmental and biological effects, but understanding is limited owing in part confounding biosocial factors. Early intervention and longitudinal support of the infant and family promote better outcomes.